Avisi Technologies’ investigational device exemption (IDE) submission for its glaucoma treatment device VisiPlate has been approved by the US Food and Drug Administration (FDA).
Rayner's RayOne EMV Toric IOL received FDA approval after a successful pivotal IDE study, highlighting its rotational ...
Andrew G. Lee, MD, and Drew Carey, MD, highlight how chronic lymphocytic leukemia can mimic Graves’ orbitopathy, underscoring ...
Attendees of the AAO 2025 annual meeting will have a chance to preview the virtual technician training platform on October 19 ...
BVI's FineVision HP trifocal IOL, approved by the FDA, enhances the US premium IOL market with advanced optic design for multifocal vision correction. The lens features a diffractive optic design and ...
As part of Ophthalmology Times ’ 50th anniversary, this timeline highlights key technological advances in ophthalmology, beginning with breakthroughs in the 1970s that paved the way for decades of ...
The AAOP's new training platform, developed with Alchemy Vision, enhances practice efficiency and patient care through ...
Epion Therapeutics announced that the United States Food and Drug Administration (FDA) has granted Fast Track designation to ...
The US Food and Drug Administration (FDA) has selected Abeona Therapeutics’ ABO-503 gene therapy for X-linked retinoschisis ...
Pediatric progressive myopia is a growing global public health concern, linked to serious ocular complications including ...
Michaelides is professor at UCL Institute of Ophthalmology and Moorfields Eye Hospital, London.
The Polaris platform is the world’s first AI-supported and robotics-enabled surgical system developed specifically for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback